GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PT UBC Medical Indonesia Tbk (ISX:LABS) » Definitions » 3-Year EBITDA Growth Rate

PT UBC Medical Indonesia Tbk (ISX:LABS) 3-Year EBITDA Growth Rate : 0.00% (As of . 20)


View and export this data going back to 2024. Start your Free Trial

What is PT UBC Medical Indonesia Tbk 3-Year EBITDA Growth Rate?

PT UBC Medical Indonesia Tbk's EBITDA per Share for the six months ended in . 20 was Rp0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of PT UBC Medical Indonesia Tbk's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, PT UBC Medical Indonesia Tbk's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT UBC Medical Indonesia Tbk's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT UBC Medical Indonesia Tbk's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PT UBC Medical Indonesia Tbk's 3-Year EBITDA Growth Rate falls into.



PT UBC Medical Indonesia Tbk 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


PT UBC Medical Indonesia Tbk  (ISX:LABS) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


PT UBC Medical Indonesia Tbk 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PT UBC Medical Indonesia Tbk's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


PT UBC Medical Indonesia Tbk Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Jalan Rawagelam V, Pulogadung Industrial Area, Block L, No. Kav 11-13, East Jakarta, Jatinegara Subdistrict, Cakung District,, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distributor of medical devices. Its product include NeumoDx, Airdoc Retina AI, QIAstat-Dx, PCR, etc.

PT UBC Medical Indonesia Tbk Headlines